Cysteine scanning mutagenesis of transmembrane domain 10 in organic anion transporting polypeptide 1B1

Biochemistry

Volumn 53, Issue 14, 2014, Pages 2261-2270

  Ohnishi, Shuichi ^a   Hays, Amanda ^a   Hagenbuch, Bruno ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; AMINO ACIDS; CELL MEMBRANES; SULFUR COMPOUNDS;

CYSTEINE-SCANNING MUTAGENESIS; SODIUM(2-SULFONATOETHYL) METHANETHIOSULFONATE; SUBSTRATE TRANSPORTS; SUBSTRATE-BINDING SITES; SURFACE EXPRESSION; TRANS-MEMBRANE DOMAINS; TRANSMEMBRANE DOMAIN; TRANSPORT ACTIVITY;

SUBSTRATES;

CYSTEINE; HEK293 CELLS; HUMANS; MUTAGENESIS; ORGANIC ANION TRANSPORTERS;

EID: 84898840075     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi500176e     Document Type: Article

References (33)

1. Hagenbuch, B. and Stieger, B. (2013) The SLCO (former SLC21) superfamily of transporters Mol. Aspects Med. 34, 396-412
2. König, J. (2011) Uptake transporters of the human OATP family: Molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms Handb. Exp. Pharmacol. 201, 1-28
3. Hagenbuch, B. and Gui, C. (2008) Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family Xenobiotica 38, 778-801
4. König, J., Cui, Y., Nies, A. T., and Keppler, D. (2000) A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane Am. J. Physiol. 278, G156-G164
5. Roth, M., Obaidat, A., and Hagenbuch, B. (2012) OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies Br. J. Pharmacol. 165, 1260-1287
6. Park, J. W., Siekmeier, R., Lattke, P., Merz, M., Mix, C., Schuler, S., and Jaross, W. (2001) Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A J. Cardiovasc. Pharmacol. Ther. 6, 351-361
7. Regazzi, M. B., Iacona, I., Campana, C., Raddato, V., Lesi, C., Perani, G., Gavazzi, A., and Vigano, M. (1993) Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients Transplant. Proc. 25, 2732-2734
8. Simonson, S. G., Raza, A., Martin, P. D., Mitchell, P. D., Jarcho, J. A., Brown, C. D., Windass, A. S., and Schneck, D. W. (2004) Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine Clin. Pharmacol. Ther. 76, 167-177
9. Link, E., Parish, S., Armitage, J., Bowman, L., Heath, S., Matsuda, F., Gut, I., Lathrop, M., and Collins, R. (2008) SLCO1B1 variants and statin-induced myopathy -a genomewide study N. Engl. J. Med. 359, 789-799
10. Chang, C., Ekins, S., Bahadduri, P., and Swaan, P. W. (2006) Pharmacophore-based discovery of ligands for drug transporters Adv. Drug Delivery Rev. 58, 1431-1450
11. Karlgren, M., Ahlin, G., Bergstrom, C. A., Svensson, R., Palm, J., and Artursson, P. (2012) In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions Pharm. Res. 29, 411-426
12. Chang, C., Pang, K. S., Swaan, P. W., and Ekins, S. (2005) Comparative pharmacophore modeling of organic anion transporting polypeptides: A meta-analysis of rat OATP1A1 and human OATP1B1 J. Pharmacol. Exp. Ther. 314, 533-541
13. i determination and CoMFA analysis of nuclear receptor ligands as competitive inhibitors of OATP1B1-mediated estradiol-17β-glucuronide transport Pharmacol. Res. 60, 50-56
14. Meier-Abt, F., Mokrab, Y., and Mizuguchi, K. (2005) Organic anion transporting polypeptides of the OATP/SLCO superfamily: identification of new members in nonmammalian species, comparative modeling and a potential transport mode J. Membr. Biol. 208, 213-227
15. Gui, C. and Hagenbuch, B. (2008) Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport Biochemistry 47, 9090-9097
16. Mandery, K., Sticht, H., Bujok, K., Schmidt, I., Fahrmayr, C., Balk, B., Fromm, M. F., and Glaeser, H. (2011) Functional and structural relevance of conserved positively charged lysine residues in organic anion transporting polypeptide 1B3 Mol. Pharmacol. 80, 400-406
17. Li, N., Hong, W., Huang, H., Lu, H., Lin, G., and Hong, M. (2012) Identification of amino acids essential for estrone-3-sulfate transport within transmembrane domain 2 of organic anion transporting polypeptide 1B1 PLoS One 7, e36647
18. Huang, J., Li, N., Hong, W., Zhan, K., Yu, X., Huang, H., and Hong, M. (2013) Conserved tryptophan residues within putative transmembrane domain 6 affect transport function of organic anion transporting polypeptide 1B1 Mol. Pharmacol. 84, 521-527
19. Miyagawa, M., Maeda, K., Aoyama, A., and Sugiyama, Y. (2009) The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta- d -glucuronide J. Pharmacol. Exp. Ther. 329, 551-557
20. Gui, C. and Hagenbuch, B. (2009) Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1 Protein Sci. 18, 2298-2306
21. Weaver, Y. M. and Hagenbuch, B. (2010) Several conserved positively charged amino acids in OATP1B1 are involved in binding or translocation of different substrates J. Membr. Biol. 236, 279-290
22. DeGorter, M. K., Ho, R. H., Leake, B. F., Tirona, R. G., and Kim, R. B. (2012) Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity Mol. Pharm. 9, 986-995
23. +-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition J. Biol. Chem. 279, 7213-7222
24. Tamai, I., Nozawa, T., Koshida, M., Nezu, J., Sai, Y., and Tsuji, A. (2001) Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C Pharm. Res. 18, 1262-1269
25. Noe, J., Portmann, R., Brun, M. E., and Funk, C. (2007) Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3 Drug Metab. Dispos. 35, 1308-1314
26. Choi, Y., Sims, G. E., Murphy, S., Miller, J. R., and Chan, A. P. (2012) Predicting the functional effect of amino acid substitutions and indels PLoS One 7, e46688
27. Bromberg, Y. and Rost, B. (2007) SNAP: predict effect of non-synonymous polymorphisms on function Nucleic Acids Res. 35, 3823-3835
28. Yamashiro, W., Maeda, K., Hirouchi, M., Adachi, Y., Hu, Z., and Sugiyama, Y. (2006) Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans Drug Metab. Dispos. 34, 1247-1254
29. Hänggi, E., Grundschober, A. F., Leuthold, S., Meier, P. J., and St-Pierre, M. V. (2006) Functional analysis of the extracellular cysteine residues in the human organic anion transporting polypeptide, OATP2B1 Mol. Pharmacol. 70, 806-817
30. Gui, C., Miao, Y., Thompson, L., Wahlgren, B., Mock, M., Stieger, B., and Hagenbuch, B. (2008) Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3 Eur. J. Pharmacol. 584, 57-65
31. Nakai, D., Nakagomi, R., Furuta, Y., Tokui, T., Abe, T., Ikeda, T., and Nishimura, K. (2001) Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes J. Pharmacol. Exp. Ther. 297, 861-867
32. König, J., Cui, Y., Nies, A. T., and Keppler, D. (2000) Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide J. Biol. Chem. 275, 23161-23168
33. Hirano, M., Maeda, K., Shitara, Y., and Sugiyama, Y. (2004) Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans J. Pharmacol. Exp. Ther. 311, 139-146